LGT Capital Partners Ltd. has filed a Form 13F-HR report disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing details the firm's investment portfolio, which includes positions in a diverse range of public companies across various sectors.
The report identifies the firm's compliance officer, Marco Aufdereggen, and lists two related entities—LGT Capital Partners (Asia-Pacific) Ltd. and LGT Capital Partners (USA) Inc.—that share discretion over the reported securities. The filing notes that the designation of 'DFND' for certain securities was made to accurately reflect the sharing of discretion between these related entities, which are under common control.
The portfolio includes significant positions in technology and healthcare companies. Notable holdings include Apple Inc., with 75,132,642 shares; Microsoft Corporation, with 99,661,599 shares; NVIDIA Corporation, with 134,901,782 shares; and Alphabet Inc. Class A, with 105,539,314 shares. In the healthcare sector, Eli Lilly & Co. is listed with 16,604,098 shares, while Boston Scientific Corp. holds 25,949,925 shares.
Other disclosed positions include Taiwan Semiconductor Manufacturing Company Sponsored ADSs with 73,793,294 shares, Agilent Technologies Inc. with 56,509,581 shares, and Netflix Inc. with 29,369,718 shares.
